BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 10453010)

  • 21. Capsaicin inhibits IFN-gamma-induced MHC class II expression by suppressing transcription of class II transactivator gene in murine peritoneal macrophages.
    Mahmoud ME; Nikami H; Shiina T; Takewaki T; Shimizu Y
    Int Immunopharmacol; 2010 Jan; 10(1):86-90. PubMed ID: 19825429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational control of MHC class II I-A molecules by IFN-gamma.
    Goñalons E; Barrachina M; García-Sanz JA; Celada A
    J Immunol; 1998 Aug; 161(4):1837-43. PubMed ID: 9712051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
    Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
    Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural resistance to infection with intracellular pathogens: cross-talk between Nramp1 and Lps genes.
    Kovárová H; Hajdúch M; Macela A
    Electrophoresis; 1997 Dec; 18(14):2654-60. PubMed ID: 9527496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
    Han Y; Zhou ZH; Ransohoff RM
    J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
    Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.
    Lee YJ; Han Y; Lu HT; Nguyen V; Qin H; Howe PH; Hocevar BA; Boss JM; Ransohoff RM; Benveniste EN
    J Immunol; 1997 Mar; 158(5):2065-75. PubMed ID: 9036950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pRB is required for interferon-gamma-induction of the MHC class II abeta gene.
    Zhu X; Pattenden S; Bremner R
    Oncogene; 1999 Sep; 18(35):4940-7. PubMed ID: 10490828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
    Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
    J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.
    Xi H; Goodwin B; Shepherd AT; Blanck G
    Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-gamma regulates nucleoside transport systems in macrophages through signal transduction and activator of transduction factor 1 (STAT1)-dependent and -independent signalling pathways.
    Soler C; Felipe A; García-Manteiga J; Serra M; Guillén-Gómez E; Casado FJ; MacLeod C; Modolell M; Pastor-Anglada M; Celada A
    Biochem J; 2003 Nov; 375(Pt 3):777-83. PubMed ID: 12868960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of natural resistance to mycobacterial infections.
    Radzioch D; Kramnik I; Skamene E
    Circ Shock; 1994 Nov; 44(3):115-20. PubMed ID: 7600634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages.
    Govoni G; Vidal S; Cellier M; Lepage P; Malo D; Gros P
    Genomics; 1995 May; 27(1):9-19. PubMed ID: 7665187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coordinate induction of Ia alpha, beta, and Ii mRNA in a macrophage cell line.
    Paulnock-King D; Sizer KC; Freund YR; Jones PP; Parnes JR
    J Immunol; 1985 Jul; 135(1):632-6. PubMed ID: 3923113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell.
    Watanabe Y; Jacob CO
    J Immunol; 1991 Feb; 146(3):899-905. PubMed ID: 1899098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4.
    Cao H; Wolff RG; Meltzer MS; Crawford RM
    J Immunol; 1989 Dec; 143(11):3524-31. PubMed ID: 2479682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
    J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteome study of Francisella tularensis live vaccine strain-containing phagosome in Bcg/Nramp1 congenic macrophages: resistant allele contributes to permissive environment and susceptibility to infection.
    Kovárová H; Halada P; Man P; Golovliov I; Krocová Z; Spacek J; Porkertová S; Necasová R
    Proteomics; 2002 Jan; 2(1):85-93. PubMed ID: 11788995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.